Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Neural Regulation01:37

Neural Regulation

43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

954
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
954

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photoinduced Enhancement of Chemical Shift Sensitivity to Local Vibrations.

Journal of the American Chemical Society·2026
Same author

Mechano-activation of osteocytic connexin hemichannels prime microenvironment in suppressing breast cancer bone metastasis.

Cancer letters·2026
Same author

Rest-activity rhythmicity as digital biomarkers of postoperative recovery and complications in children.

Digital health·2026
Same author

Striatal Tau Pathology Underlies Monoaminergic Disruption in Progressive Supranuclear Palsy.

Clinical nuclear medicine·2026
Same author

TaxEL: Taxonomy-Enhanced Entity Representation Learning for Biomedical Entity Linking.

IEEE journal of biomedical and health informatics·2026
Same author

Occipital and parietal non-invasive brain stimulation enhances perceptual learning and transfer: evidence from high-frequency tRNS.

Frontiers in neuroscience·2026

Related Experiment Video

Updated: Jan 11, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K

Automated MRI-Based Classification of Parkinsonism: A Deep Learning Approach to Distinguish PD From PSP.

Xiaofei Hu1,2, Zehong Cao3, Tianbin Song1

  • 1Xuanwu Hospital, Capital Medical University, Beijing, China.

CNS Neuroscience & Therapeutics
|November 13, 2025
PubMed
Summary

An automated Magnetic Resonance Parkinsonism Index (MRPI) method accurately distinguishes Parkinson's disease (PD) from progressive supranuclear palsy (PSP). This AI-driven approach enhances diagnostic reliability for neurodegenerative conditions.

Keywords:
Parkinson's diseaseautomated MRI‐based classificationdeep learningmagnetic resonance parkinsonism indexprogressive supranuclear palsy

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.0K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

Related Experiment Videos

Last Updated: Jan 11, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.0K
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.1K

Area of Science:

  • Neuroimaging
  • Artificial Intelligence in Medicine
  • Neurology

Background:

  • Differentiating Parkinson's disease (PD) from progressive supranuclear palsy (PSP) is clinically significant due to differing treatment strategies.
  • The Magnetic Resonance Parkinsonism Index (MRPI) shows diagnostic potential, but manual calculations introduce variability.
  • Developing automated methods for MRPI calculation is essential for clinical applicability.

Purpose of the Study:

  • To develop a fully automated algorithm for calculating MRPI 1.0 and MRPI 2.0.
  • To evaluate the automated algorithm's efficacy in differentiating PD from PSP across two distinct Chinese cohorts.
  • To assess the diagnostic performance of automated MRPI compared to manual assessments.

Main Methods:

  • Utilized deep learning-based super-resolution to enhance 2D MRI data into high-resolution images.
  • Automated alignment and parcellation of structural MRI data for MRPI 1.0 and 2.0 measurement.
  • Constructed a logistic regression model using automated MRPI values to distinguish PD from PSP.

Main Results:

  • The automated MRPI 2.0 demonstrated superior diagnostic accuracy (AUC=0.78) compared to MRPI 1.0.
  • The automated method exhibited strong linear correlation with manual radiologist assessments, confirming reliability.
  • Automated MRPI achieved an average AUC of 0.85 for identifying PSP from PD.

Conclusions:

  • The automated MRPI method offers improved diagnostic accuracy and clinical applicability for differentiating PD from PSP.
  • Integration of super-resolution techniques enhances MRPI's utility as a neuroimaging biomarker.
  • This automated approach provides a reliable tool for distinguishing these neurodegenerative parkinsonian syndromes.